EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Epstein–Barr virus envelope glycoprotein 110 inhibits NF-κB activation by interacting with NF-κB subunit p65

Mingsheng Cai, Bin Xiao, Yuanfang Wang, Kezhen Wang, Wenqi Luo, Jiangqin Fu, Shuai Wang, Shenyu Deng, Bolin Li, Lan Gong, Jiayi Zhong, Li Hu und 12 weitere

Journal of Biological Chemistry · 2023

DOI: 10.1016/j.jbc.2023.104613 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023. Verfasst von Mingsheng Cai und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital; State Key Laboratory of…. Hauptthemen laut MEDLINE: NF-kappa B, Epstein-Barr Virus Infections. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, Guangzhou Science and Technology Program key projects.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epstein-Barr virus (EBV) is a member of the lymphotropic virus family and is highly correlated with some human malignant tumors. It has been reported that envelope glycoprotein 110 (gp110) plays an essential role in viral fusion, DNA replication, and nucleocapsid assembly of EBV. However, it has not been established whether gp110 is involved in regulating the host's innate immunity. In this study, we found that gp110 inhibits tumor necrosis factor α-mediated NF- κB promoter activity and the downstream production of NF- κB-regulated cytokines under physiological conditions. Using dual-luciferase reporter assays, we showed that gp110 might impede the NF-κB promoter activation downstream of NF-κB transactivational subunit p65. Subsequently, we used coimmunoprecipitation assays to demonstrate that gp110 interacts with p65 during EBV lytic infection, and that the C-terminal cytoplasmic region of gp110 is the key interaction domain with p65. Furthermore, we determined that gp110 can bind to the N-terminal Rel homologous and C-terminal domains of p65. Alternatively, gp110 might not disturb the association of p65 with nontransactivational subunit p50, but we showed it restrains activational phosphorylation (at Ser536) and nuclear translocation of p65, which we also found to be executed by the C-terminal cytoplasmic region of gp110. Altogether, these data suggest that the surface protein gp110 may be a vital component for EBV to antagonize the host's innate immune response, which is also helpful for revealing the infectivity and pathogenesis of EBV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BEpstein-Barr Virus InfectionsHumansHerpesvirus 4, HumanTranscription Factor RelASignal TransductionProtein Transport

Stichwörter der Autor:innen

EBVNF-κBgp110innate immunity

Substanzen

NF-kappa BTranscription Factor RelA

Autor:innen und Institutionen

  • Department of Laboratory Medicine, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital; State Key Laboratory of Respiratory Disease, The Second Affiliated Hospital, Guangdong Provin…
  • School of Life Sciences, Anhui Medical University, Hefei, Anhui, China.
  • Institutes of Biology and Medical Science, Soochow University, Suzhou, Jiangsu, China.
  • School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, Guangdong, China. Electronic address: zanj@gdut.edu.cn.
  • State Key Laboratory of Respiratory Disease, Sino-French Hoffmann Institute, School of Basic Medical Science, Guangzhou Medical University, Guangzhou, Guangdong, China; Guangdong South China Vaccine, Guangzhou, Guangdon…
  • Department of Otolaryngology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China; Institute of Hearing and Speech-Language Science, Guangzhou Xinhua University, Guangzhou, Guangdong, Chin…

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province
  • Guangzhou Science and Technology Program key projects
  • Guangzhou Medical University
  • State Key Laboratory of Respiratory Disease
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Department of Education of Guangdong Province
  • National Key Research and Development Program of China

Zitieren

APA

Cai, M., Xiao, B., Wang, Y., Wang, K., Luo, W., Fu, J., Wang, S., Deng, S., Li, B., Gong, L., Zhong, J., Hu, L., Pan, L., Wang, L., Liu, Y., Huang, C., Li, X., Zeng, Q., Kang, H., …, & Li, M. (2023). Epstein–Barr virus envelope glycoprotein 110 inhibits NF-κB activation by interacting with NF-κB subunit p65. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.104613

Vancouver

Cai M, Xiao B, Wang Y, Wang K, Luo W, Fu J, et al. Epstein–Barr virus envelope glycoprotein 110 inhibits NF-κB activation by interacting with NF-κB subunit p65. Journal of Biological Chemistry. 2023. doi:10.1016/j.jbc.2023.104613

BibTeX
@article{Cai2023,
  author = {Cai, Mingsheng and Xiao, Bin and Wang, Yuanfang and Wang, Kezhen and Luo, Wenqi and Fu, Jiangqin and Wang, Shuai and Deng, Shenyu and Li, Bolin and Gong, Lan and Zhong, Jiayi and Hu, Li and Pan, Lingxia and Wang, Liding and Liu, Yintao and Huang, Chen and Li, Xiaoqing and Zeng, Qiyuan and Kang, Haoran and Li, Linhai and Zan, Jie and Peng, Tao and Yang, Haidi and Li, Meili},
  title = {Epstein–Barr virus envelope glycoprotein 110 inhibits NF-κB activation by interacting with NF-κB subunit p65},
  journal = {Journal of Biological Chemistry},
  year = {2023},
  doi = {10.1016/j.jbc.2023.104613}
}
Kostenlos starten →